Clinical trial · Observational
Clinical Outcomes of Patients with LAL+ in At Least One Eye
CLINICAL OUTCOMES of BILATERAL PSEUDOPHAKIC PATIENTS with a LIGHT ADJUSTABLE LENS+ (LAL)+ IMPLANTED in AT LEAST ONE EYE
NCT06650358CI-TRIAL-00081796enrolling by invitationClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this study is to collect data on bilateral pseudophakic patients implanted with the RxSight Light Adjustable Lens+ (LAL+) in at least one eye
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| IOL, Cataract | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Light Adjustable Lens+ | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- LAL+
- description
- Bilateral pesudophakic adults implanted with the LAL+ in at least one eye
- interventionNames
- Device: Light Adjustable Lens+
Primary outcomes (1)
- measure
- Patient Satisfaction
- timeFrame
- 3-18 months after phacoemulsification
- description
- Description: Subjective questionnaire explores the frequency/need for glasses for various visual functions at distance/intermediate/near, experience with dysphotopsias, and overall satisfaction of visual function without glasses.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Adults with bilateral pseudophakia who have been implanted with the LAL+ in at least one eye and who have completed LDD light treatments * Sign a written Informed Consent Form Exclusion Criteria: * Visually significant eye disease
References
Publications (0)
Data not yet available
No reference posted for this study.